Activated Raf-1 causes growth arrest in human small cell lung cancer cells.
Small cell lung cancer (SCLC) accounts for 25% of all lung cancers, and is almost uniformly fatal. Unlike other lung cancers, ras mutations have not been reported in SCLC, suggesting that activation of ras-associated signal transduction pathways such as the raf-MEK mitogen-activated protein kinases...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
1998
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC508551/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9421477/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI831 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
